Shares of drugmaker Strides Arcolab rose more than 19% on Tuesday after the company said it received US FDA approval to manufacture vancomycin injections at its new facility in Bangalore.
The company plans to manufacture all its approved sterile injectables from this facility and subsequently launch them in the US, it said in a statement. In an interview with CNBC-TV18, Arun Kumar, Group CEO and Vice Chairman, Strides Arcolab spoke on the development and the way forward for the company. Below is a verbatim transcript. Also watch the accompanying video. Q: If you could take us through the development and how itDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
